UBS’s Compugen CGEN Stock Holding History

UBS’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Hold	200	–	–	﹤0.01%	9967
2014 Q2	$2K	Sell	200 -1,000	-83%	-$8.99K	﹤0.01%	10001
2014 Q1	$13K	Buy	+1,200	New	+$13.2K	﹤0.01%	8593

Other funds holding CGEN

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

ACM

Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS's CGEN Position: Q3 2014 in Review

UBS increased its Compugen (CGEN) stake by 349% in Q3 2014, buying an estimated $280K and bringing the position to 40,543 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #4627.

UBS first reported a position in CGEN in Q2 2013 and has held it in 6 quarters since. 38 funds tracked by Wall St. Rank hold CGEN as of Q3 2014.

UBS held 40,543 shares of Compugen worth $347K as of Q3 2014.
UBS bought 31,509 Compugen shares in Q3 2014, an estimated $280K.
Compugen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4627 holding.
UBS first reported a position in Compugen in Q2 2013 and has held it in 6 quarters since.
38 funds tracked by Wall St. Rank held Compugen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.